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Optical Coherence Tomography Angiography Features
of Iris Racemose Hemangioma in 4 Cases
Jason L. Chien, BS; Kareem Sioufi, MD; Sandor Ferenczy, CRA, OCT-C; Emil Anthony T. Say, MD;
Carol L. Shields, MD
I ris racemose hemangioma is a benign arteriovenous mal-formation with direct artery to vein communication butwithout intervening capillarybed.1,2 Reports haveused in-
travenous fluorescein angiography (IVFA), anterior segment
(AS)optical coherence tomography (OCT), andultrasoundbio-
microscopy (UBM) todescribe featuresof this iris abnormality.3
Optical coherence tomography angiography (OCTA) was in-
troduced in the clinical setting in 2012 and is best known for
detecting retinal neovascularization, with only limited re-
ports of AS vasculature.4-8We report hereinAS imaging of iris
racemose hemangioma using OCTA.
Methods
This is a retrospective observational case series of 4 con-
secutive unilateral iris racemose hemangiomas seen on the
Ocular Oncology Service of Wills Eye Hospital, Philadelphia,
Pennsylvania, from August 2016 to November 2016. Institu-
tional review board approval of Wills Eye Hospital was
obtained, and Health Insurance Portability and Accountabil-
ity Act guidelines were followed. Written consent was
obtained from all patients.
IMPORTANCE Optical coherence tomography angiography (OCTA) allows visualization of iris
racemose hemangioma course and its relation to the normal iris microvasculature.
OBJECTIVE To describe OCTA features of iris racemose hemangioma.
DESIGN, SETTING, AND PARTICIPANTS Descriptive, noncomparative case series at a tertiary
referral center (Ocular Oncology Service of Wills Eye Hospital). Patients diagnosed with
unilateral iris racemose hemangiomawere included in the study.
MAIN OUTCOMES ANDMEASURES Features of iris racemose hemangioma onOCTA.
RESULTS Four eyes of 4 patients with unilateral iris racemose hemangioma were included
in the study. Mean patient age was 50 years, all patients were white, and Snellen visual
acuity was 20/20 in each case. All eyes had sectoral iris racemose hemangioma without
associated iris or ciliary body solid tumor on clinical examination and ultrasound
biomicroscopy. By anterior segment OCT, the racemose hemangioma was partially visualized
in all cases. By OCTA, the hemangioma was clearly visualized as a uniform large-caliber
vascular tortuous loop with intense flow characteristics superimposed over small-caliber
radial iris vessels against a background of low-signal iris stroma. The vascular course on
OCTA resembled a light bulb filament (filament sign), arising from the peripheral iris (base of
light bulb) and forming a tortuous loop on reaching its peak (midfilament) near the pupil
(n = 3) or midzonal iris (n = 1), before returning to the peripheral iris (base of light bulb).
Intravenous fluorescein angiography performed in 1 eye depicted the iris hemangioma; how-
ever, small-caliber radial iris vessels were more distinct on OCTA than intravenous fluorescein
angiography.
CONCLUSIONS AND RELEVANCE Optical coherence tomography angiography is a noninvasive
vascular imagingmodality that clearly depicts the looping course of iris racemose
hemangioma. Optical coherence tomography angiography depicted fine details of radial iris
vessels, not distinct on intravenous fluorescein angiography.
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All patients underwent comprehensive ophthalmic ex-
amination including slitlamp evaluation and photography,
dilated funduscopic examination, UBM,AS-OCT, IVFA (when
possible), and OCTA. Optical coherence tomography angiog-
raphy was performed with Optovue RTVue XR Avanti, ver-
sion 2016.1.0.26 (Optovue Inc).9 For ASOCTA, a volume cube
scanprotocolwasused toscan the lesion (3.00 × 3.00mm;An-
gioRetina); however, the Z-motor positioning and focus set-
tings were adjustedmanually to allow visualization of the AS
andprecise focus of theOCTB-scan, and the P-motorwas au-
tomatically adjusted.
Patient demographics (including age, race/ethnicity, and
sex)andreferraldiagnoseswere recorded.Data regardingclini-
cal features included affected eye, visual acuity, iris color, tu-
mor clock-hour location, tumor size (number of clock hours),
andpresenceof irisor ciliarybodymass. Imaging featureswere
recorded from UBM, AS-OCT, IVFA, and OCTA, including vi-
sualization of hemangioma, vascular course, and heman-
gioma type (simple vs complex).10
Results
Mean age was 50 years (range, 43-67 years), and all patients
werewhitewith bilateral 20/20 visual acuity. By slitlampbio-
microscopy, thehemangiomawasminimallyvisiblewithin the
iris stroma as a large, dark-red vessel with a tortuous course
buriedwithinnormal stromal tissuewithout solid tumor in the
iris or ciliary body. The hemangioma was located temporally
or inferotemporally in the right (n = 3) or left (n = 1) eye and
demonstrated 1.0-1.5 clock hours of involvement (Table).
On UBM, the hemangioma could not be identified. Ante-
rior segment OCT over the hemangioma showed its lumen
as a hyporeflective spherical core with poorly delineated
margins against normal iris stroma and vasculature. By
OCTA, the hemangioma appeared as a uniform, large-caliber
vascular tortuous loop without aneurysmal changes, and
with intense flow characteristics superimposed over small-
caliber radial iris vessels against a background of low-signal
iris stroma. The vascular course on OCTA resembled a light
bulb filament (filament sign), arising from the peripheral iris
(light bulb base) and forming a tortuous loop on reaching its
peak (midfilament) near the pupil (n = 3, Figure 1B and D
and Figure 2D) or midzonal iris (n = 1, Figure 1F), before
returning to the peripheral iris (light bulb base). Optical
coherence tomography angiography was not able to visual-
Key Points
Question How does iris racemose hemangioma appear by optical
coherence tomography angiography?
Finding In this case series using optical coherence tomography
angiography, iris racemose hemangioma appears as a large-caliber
vascular tortuous loop with intense flow characteristics
superimposed over small-caliber radial iris vessels against a
background of low-signal iris stroma. It resembles a light bulb
filament (filament sign), arising from the peripheral iris (base of
light bulb), forming a tortuous loop on reaching its peak
(midfilament) near the pupil or midzonal iris, before returning to
the peripheral iris (base of light bulb).
Meaning These findings suggest iris racemose hemangioma has
distinct features on optical coherence tomography angiography.
Table. Iris Racemose Hemangioma: Clinical and Imaging Features in 4 Cases
Demographics Patient 1 Patient 2 Patient 3 Patient 4
Age, y 45 43 43 67
Race/ethnicity White White White White
Sex Female Male Male Female
Referral diagnosis Iris lesion Iris lesion Iris lesion Iris lesion
Clinical features
Involved eye Right Right Right Left
Visual acuity 20/20 20/20 20/20 20/20
Iris color Blue Blue Green Green
Clock hours, h:min 7:00-8:30 7:00-8:30 9:00-10:00 4:00-5:30
Iris or ciliary body massa Negative Negative Negative Negative
Imaging features
UBM Indistinct Indistinct Indistinct Indistinct
AS-OCT
Visualization Partialb Partialb Partialb Partialb
IVFA
Visualization NA NA NA Yes
Vascular course NA NA NA PI-Pupil-PI
Hemangioma type NA NA NA Simple
OCTA
Visualization Yes Yes Yes Yes
Vascular course PI-Pupil-PI PI-Pupil-PI PI-Midzone-PI PI-Pupil-PI
Hemangioma type Simple Complex Simple Simple
Abbreviations: AS-OCT, anterior
segment optical coherence
tomography; IVFA, intravenous
fluorescein angiography; NA, not
applicable/not done; OCTA, optical
coherence tomography angiography;
PI, peripheral iris; UBM, ultrasound
biomicroscopy.
a Imaged using UBM and AS-OCT.
b Lumen of racemose hemangioma
was partially visualized.
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ize vascular details in the angle; hence, it was difficult to
ascertain the exact origin of the hemangioma by OCTA. In
the 1 case that received AS IVFA, the vascular course of the
hemangioma was delineated on AS IVFA; however, details
regarding relationship to normal iris microvasculature were
not fully captured on AS IVFA (Figure 2B and C).
Discussion
Optical coherence tomography angiography can provide
vascular imaging capability of iris and conjunctival
tumors.6-8 Skalet et al6 showed increased intratumoral vas-
cular density in iris melanomas compared with benign iris
nevi using AS OCTA. Kang et al7 demonstrated iris micro-
hemangiomatosis by OCTA, delineating pinpoint vascular
lesions with flow arising from the posterior iris stroma,
while Chien et al8 used OCTA to visualize abundant vascula-
ture within conjunctival racemose hemangioma not seen on
IVFA.
In this study, we found that commercially available OCTA
showedremarkableclinicalutility for imaging iris racemosehe-
mangioma.Cases in this studyhad lightlypigmented irides. In
the iris, detectionof flowsignal dependson iris color, and flow
isbestdetected in lightlycolored irides.6Thus,our findingsmay
notbe replicable indarklypigmented irides. Further,OCTAal-
lowed detailed visualization of the hemangioma in relation to
the normal iris vasculature not possible with slitlamp exami-
nation,particularlywhentheyweredeepwithin the iris stroma
asdemonstrated inpatients 1, 2, and4.Forpatient4,OCTApro-
vided visualization of the hemangioma superimposed on the
normal radial iris vessels, while the normal radial iris vessels
were not distinctly visualized on IVFA. This is likely owing to
the long operating wavelength of OCTA, allowing better
Figure 1. Iris Racemose HemangiomaUnder Slitlamp Photographs (A, C, and E) and Corresponding Optical
Coherence Tomography Angiography (B, D, and F)
Slitlamp photographA Optical coherence tomography angiographyB
Slitlamp photographC Optical coherence tomography angiographyD
Slitlamp photographE Optical coherence tomography angiographyF
Optical coherence tomography
angiography showed all iris racemose
hemangiomas to be of uniform
vascular caliber with a consistent
looping course extending from the
peripheral iris (yellow arrowheads) to
the pupillary margin (red arrowhead)
or midzonal iris (blue arrowhead).
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stromal tissue penetration, while IVFA exhibits diminished
transmission of fluorescence through iris stroma.
Differentiation of iris racemose hemangioma from other
vascular lesions is important. Iris racemosehemangioma is the
most frequent iris vascular tumor and canbedistinguishedby
its characteristicuniformvascularpattern, loopingcourse, and
location.2,10 Inthisstudy,OCTAshowedracemosehemangioma
emanates from theperipheral iris and courses to thepupillary
margin ormidzonal region, forming a tortuous loopbefore re-
turning to theperipheral iris. In contrast, irismicrohemangio-
matosis is aminute nodular vascular sac at the pupillarymar-
gin, producing transient and intermittenthyphema,10-12while
iris neovascularization appears as fine, thread-likehaphazard
vascularizationof the iris stromaemanating fromthepupillary
margin or the angle.10,13
Limitations
The characteristic vascular pattern of iris racemose heman-
giomawas identifiedonbothOCTAand traditional IVFA.How-
ever, it is important torealizeseveral limitationsofeachmethod
and that each should not be used interchangeably. Intrave-
nous fluorescein angiography is limitedby light penetranceof
deeper tissue and vascular leakage that can obscure micro-
vascular details. Conversely, OCTA is limited by motion arti-
fact and its inability to detect some flow patterns, especially
vascular leakage. In caseswhere iris vascular lesions are clini-
cally indistinguishable, features on IVFA could potentially al-
low differentiation because iris racemose hemangioma does
not leak, while iris neovascularization typically exhibits slow
leakage of dye into the aqueous.10,13 In terms of time effi-
ciency,OCTAmaybeadvantageousbecause it allowsaquicker
noninvasive evaluationof irismicrovasculature. Further, only
lightlypigmented irideswere imagedusingcommerciallyavail-
able OCTA. Light penetrance using superluminescent diode
typically used in spectral domain OCT may not be sufficient
for darker irides. Also, all patients scanned in this series had
excellent cooperation during image acquisition. Anterior
segment OCTA imaging requires patient cooperation
because eye tracking and motion correction used for poste-
rior segment OCTA demonstrate less proficiency when
applied to the AS.
Conclusions
In summary, we report OCTA features in 4 cases of iris rac-
emose hemangioma. Optical coherence tomography angiog-
raphy allowedvisualizationof the characteristic uniformvas-
cular caliber and looping course of iris racemosehemangioma
and provided information in relation to normal irismicrovas-
culature. Future improvements in OCTA technology may al-
low improved details and extend limitations on iris color.
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Figure 2. Iris Racemose HemangiomaUnder Slitlamp Photograph, Early-Phase and Late-Phase Intravenous Fluorescein Angiography,
and Optical Coherence Tomography Angiography
Slitlamp photographA Early-phase intravenous fluorescein
angiography
B Late-phase intravenous fluorescein
angiography
C Optical coherence tomography
angiography
D
Optical coherence tomography angiography (D) showed dilated tortuous
hyperreflective vascular lesion consistent with iris racemose hemangiomawith
looping course of vessel from the peripheral iris (yellow arrowhead) toward the
pupillary margin (red arrowhead) and back to the peripheral iris (yellow
arrowhead). Small-caliber normal radial iris vessels (blue arrowhead) were more
distinct on optical coherence tomography angiography (D) than early (B; 35
seconds) and late (C; 2:05minutes) phase intravenous fluorescein angiography.
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